HFL-Park Place is a joint venture between Haden Freeman Group and Park Place Research.

Haden Freeman Limited (HFL) is well known for its expertise in the design and construction of pharmaceutical ingredient (API) plants for the application of risk-based approach to process control technology and systems. Park Place Research is focussed on strategic process research and development and has a leading knowledge of crystallisation processes, as well as the application of innovative process analytical technology (PAT) solutions to manufacturing processes.